Axcelis

ACLS

Market cap $2.56B

From a technical perspective, Axcelis Technologies (ACLS) is looking like an interesting pick, as it just reached a key level of support. ACLS recently overtook the 50-day moving average, and this suggests a short-term bullish trend.

From a technical perspective, Axcelis Technologies (ACLS) is looking like an interesting pick, as it just reached a key level of support. ACLS recently overtook the 20-day moving average, and this suggests a short-term bullish trend.

Axcelis (ACLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

BEVERLY, Mass. , Nov. 6, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences: The Wells Fargo 9th Annual TMT Summit on November 18, 2025 at the Terranea Resort, Rancho Palos Verdes, CA.

Axcelis Technologies, Inc. ( ACLS ) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants David Ryzhik - Senior Vice President of Investor Relations and Corporate Strategy Russell Low - CEO, President & Director James Coogan - Executive VP & CFO Conference Call Participants Jonathan Dorsheimer - William Blair & Company L.L.C., Research Division Craig Ellis - B.

Axcelis Technologies (ACLS) came out with quarterly earnings of $1.21 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $1.49 per share a year ago.

Q3 Highlights: Revenue of $213.6 million GAAP Gross Margin of 41.6%, and Non-GAAP Gross Margin of 41.8% GAAP Operating Margin of 11.7% and Non-GAAP Operating Margin of 18.2% GAAP Diluted earnings per share of $0.83, and Non-GAAP Diluted earnings per share of $1.21 BEVERLY, Mass. , Nov. 4, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the third quarter ended September 30, 2025.

Bought 91,788 shares of Axcelis Technologies (NASDAQ: ACLS); estimated at ~$7.39 million based on the average price in the third quarter of 2025 Transaction value represents 0.24% of reportable AUM Post-trade stake: 1,610,332 shares valued at $157.23 million Axcelis Technologies is now the fund's 1st-largest holding, at 5.1% of AUM

In the latest trading session, Axcelis Technologies (ACLS) closed at $82.29, marking a -1.15% move from the previous day.

BEVERLY, Mass. , Oct. 22, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the third quarter 2025 before the opening of the market on Tuesday, November 4, 2025.